Elongation of fatty acids protein, responsible for very long carbon chain llipid biosynthesis (conserved in Eukaryota).. This group of enzymes has expanded heavily in kinetoplastids.. Localization: ER (by homology)
Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 45 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 1, no: 37 |
NetGPI | no | yes: 0, no: 38 |
Term | Name | Level | Count |
---|---|---|---|
GO:0016020 | membrane | 2 | 33 |
GO:0110165 | cellular anatomical entity | 1 | 34 |
GO:0005737 | cytoplasm | 2 | 1 |
Related structures:
AlphaFold database: Q4QFR8
Term | Name | Level | Count |
---|---|---|---|
GO:0000038 | very long-chain fatty acid metabolic process | 5 | 6 |
GO:0001676 | long-chain fatty acid metabolic process | 5 | 4 |
GO:0006082 | organic acid metabolic process | 3 | 39 |
GO:0006629 | lipid metabolic process | 3 | 39 |
GO:0006631 | fatty acid metabolic process | 4 | 39 |
GO:0006633 | fatty acid biosynthetic process | 5 | 39 |
GO:0006643 | membrane lipid metabolic process | 4 | 6 |
GO:0006665 | sphingolipid metabolic process | 4 | 6 |
GO:0006807 | nitrogen compound metabolic process | 2 | 6 |
GO:0008152 | metabolic process | 1 | 39 |
GO:0008610 | lipid biosynthetic process | 4 | 39 |
GO:0009058 | biosynthetic process | 2 | 39 |
GO:0009987 | cellular process | 1 | 39 |
GO:0016053 | organic acid biosynthetic process | 4 | 39 |
GO:0019367 | fatty acid elongation, saturated fatty acid | 7 | 6 |
GO:0019368 | fatty acid elongation, unsaturated fatty acid | 7 | 6 |
GO:0019752 | carboxylic acid metabolic process | 5 | 39 |
GO:0030148 | sphingolipid biosynthetic process | 5 | 6 |
GO:0030497 | fatty acid elongation | 6 | 6 |
GO:0032787 | monocarboxylic acid metabolic process | 6 | 39 |
GO:0034625 | fatty acid elongation, monounsaturated fatty acid | 8 | 6 |
GO:0034626 | fatty acid elongation, polyunsaturated fatty acid | 8 | 6 |
GO:0042759 | long-chain fatty acid biosynthetic process | 6 | 4 |
GO:0042761 | very long-chain fatty acid biosynthetic process | 6 | 6 |
GO:0043436 | oxoacid metabolic process | 4 | 39 |
GO:0044237 | cellular metabolic process | 2 | 39 |
GO:0044238 | primary metabolic process | 2 | 39 |
GO:0044249 | cellular biosynthetic process | 3 | 39 |
GO:0044255 | cellular lipid metabolic process | 3 | 39 |
GO:0044281 | small molecule metabolic process | 2 | 39 |
GO:0044283 | small molecule biosynthetic process | 3 | 39 |
GO:0046394 | carboxylic acid biosynthetic process | 5 | 39 |
GO:0046467 | membrane lipid biosynthetic process | 4 | 6 |
GO:0071704 | organic substance metabolic process | 2 | 39 |
GO:0072330 | monocarboxylic acid biosynthetic process | 6 | 39 |
GO:1901564 | organonitrogen compound metabolic process | 3 | 6 |
GO:1901566 | organonitrogen compound biosynthetic process | 4 | 6 |
GO:1901576 | organic substance biosynthetic process | 3 | 39 |
Term | Name | Level | Count |
---|---|---|---|
GO:0003824 | catalytic activity | 1 | 39 |
GO:0004312 | fatty acid synthase activity | 5 | 39 |
GO:0009922 | fatty acid elongase activity | 6 | 39 |
GO:0016740 | transferase activity | 2 | 39 |
GO:0016746 | acyltransferase activity | 3 | 39 |
GO:0016747 | acyltransferase activity, transferring groups other than amino-acyl groups | 4 | 39 |
GO:0102756 | very-long-chain 3-ketoacyl-CoA synthase activity | 5 | 39 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 2 | 6 | PF00656 | 0.251 |
CLV_NRD_NRD_1 | 137 | 139 | PF00675 | 0.322 |
CLV_NRD_NRD_1 | 264 | 266 | PF00675 | 0.274 |
CLV_NRD_NRD_1 | 89 | 91 | PF00675 | 0.379 |
CLV_PCSK_KEX2_1 | 137 | 139 | PF00082 | 0.300 |
CLV_PCSK_KEX2_1 | 282 | 284 | PF00082 | 0.504 |
CLV_PCSK_PC1ET2_1 | 137 | 139 | PF00082 | 0.334 |
CLV_PCSK_PC1ET2_1 | 282 | 284 | PF00082 | 0.530 |
CLV_PCSK_SKI1_1 | 193 | 197 | PF00082 | 0.340 |
CLV_PCSK_SKI1_1 | 57 | 61 | PF00082 | 0.292 |
DEG_Nend_UBRbox_2 | 1 | 3 | PF02207 | 0.346 |
DOC_CYCLIN_yCln2_LP_2 | 194 | 200 | PF00134 | 0.521 |
DOC_MAPK_gen_1 | 192 | 202 | PF00069 | 0.409 |
DOC_MAPK_MEF2A_6 | 196 | 204 | PF00069 | 0.467 |
DOC_PP4_FxxP_1 | 40 | 43 | PF00568 | 0.310 |
DOC_USP7_MATH_1 | 269 | 273 | PF00917 | 0.703 |
DOC_USP7_UBL2_3 | 192 | 196 | PF12436 | 0.472 |
DOC_USP7_UBL2_3 | 225 | 229 | PF12436 | 0.172 |
DOC_USP7_UBL2_3 | 91 | 95 | PF12436 | 0.172 |
LIG_AP2alpha_1 | 126 | 130 | PF02296 | 0.399 |
LIG_APCC_ABBA_1 | 250 | 255 | PF00400 | 0.382 |
LIG_BRCT_BRCA1_1 | 253 | 257 | PF00533 | 0.299 |
LIG_BRCT_BRCA1_2 | 253 | 259 | PF00533 | 0.367 |
LIG_EH1_1 | 173 | 181 | PF00400 | 0.351 |
LIG_eIF4E_1 | 79 | 85 | PF01652 | 0.204 |
LIG_FHA_1 | 127 | 133 | PF00498 | 0.311 |
LIG_FHA_1 | 148 | 154 | PF00498 | 0.275 |
LIG_FHA_1 | 206 | 212 | PF00498 | 0.398 |
LIG_FHA_1 | 233 | 239 | PF00498 | 0.345 |
LIG_FHA_1 | 54 | 60 | PF00498 | 0.516 |
LIG_FHA_1 | 79 | 85 | PF00498 | 0.217 |
LIG_LIR_Apic_2 | 37 | 43 | PF02991 | 0.346 |
LIG_LIR_Gen_1 | 144 | 154 | PF02991 | 0.361 |
LIG_LIR_Gen_1 | 163 | 174 | PF02991 | 0.217 |
LIG_LIR_Gen_1 | 178 | 189 | PF02991 | 0.356 |
LIG_LIR_Gen_1 | 217 | 226 | PF02991 | 0.418 |
LIG_LIR_Nem_3 | 128 | 133 | PF02991 | 0.458 |
LIG_LIR_Nem_3 | 144 | 149 | PF02991 | 0.327 |
LIG_LIR_Nem_3 | 163 | 169 | PF02991 | 0.215 |
LIG_LIR_Nem_3 | 178 | 184 | PF02991 | 0.318 |
LIG_LIR_Nem_3 | 188 | 194 | PF02991 | 0.459 |
LIG_LIR_Nem_3 | 217 | 223 | PF02991 | 0.324 |
LIG_LIR_Nem_3 | 74 | 79 | PF02991 | 0.304 |
LIG_PCNA_PIPBox_1 | 1 | 10 | PF02747 | 0.388 |
LIG_Pex14_2 | 126 | 130 | PF04695 | 0.391 |
LIG_Pex14_2 | 142 | 146 | PF04695 | 0.334 |
LIG_Pex14_2 | 152 | 156 | PF04695 | 0.332 |
LIG_Pex14_2 | 216 | 220 | PF04695 | 0.204 |
LIG_Pex14_2 | 253 | 257 | PF04695 | 0.286 |
LIG_SH2_CRK | 79 | 83 | PF00017 | 0.268 |
LIG_SH2_PTP2 | 201 | 204 | PF00017 | 0.350 |
LIG_SH2_PTP2 | 261 | 264 | PF00017 | 0.522 |
LIG_SH2_STAP1 | 154 | 158 | PF00017 | 0.349 |
LIG_SH2_STAP1 | 181 | 185 | PF00017 | 0.404 |
LIG_SH2_STAT5 | 107 | 110 | PF00017 | 0.272 |
LIG_SH2_STAT5 | 174 | 177 | PF00017 | 0.349 |
LIG_SH2_STAT5 | 181 | 184 | PF00017 | 0.308 |
LIG_SH2_STAT5 | 201 | 204 | PF00017 | 0.425 |
LIG_SH2_STAT5 | 215 | 218 | PF00017 | 0.330 |
LIG_SH2_STAT5 | 246 | 249 | PF00017 | 0.319 |
LIG_SH2_STAT5 | 251 | 254 | PF00017 | 0.308 |
LIG_SH2_STAT5 | 261 | 264 | PF00017 | 0.442 |
LIG_SH2_STAT5 | 30 | 33 | PF00017 | 0.299 |
LIG_SH2_STAT5 | 35 | 38 | PF00017 | 0.305 |
LIG_SH2_STAT5 | 7 | 10 | PF00017 | 0.339 |
LIG_UBA3_1 | 117 | 122 | PF00899 | 0.322 |
LIG_UBA3_1 | 252 | 259 | PF00899 | 0.295 |
LIG_WRC_WIRS_1 | 215 | 220 | PF05994 | 0.306 |
LIG_WRC_WIRS_1 | 35 | 40 | PF05994 | 0.363 |
MOD_CK1_1 | 219 | 225 | PF00069 | 0.274 |
MOD_CMANNOS | 63 | 66 | PF00535 | 0.378 |
MOD_Cter_Amidation | 135 | 138 | PF01082 | 0.284 |
MOD_GlcNHglycan | 271 | 274 | PF01048 | 0.481 |
MOD_GSK3_1 | 175 | 182 | PF00069 | 0.385 |
MOD_GSK3_1 | 269 | 276 | PF00069 | 0.632 |
MOD_N-GLC_1 | 231 | 236 | PF02516 | 0.544 |
MOD_NEK2_1 | 118 | 123 | PF00069 | 0.313 |
MOD_NEK2_1 | 126 | 131 | PF00069 | 0.320 |
MOD_NEK2_1 | 175 | 180 | PF00069 | 0.295 |
MOD_NEK2_1 | 200 | 205 | PF00069 | 0.481 |
MOD_NEK2_1 | 214 | 219 | PF00069 | 0.269 |
MOD_NEK2_1 | 61 | 66 | PF00069 | 0.471 |
MOD_NEK2_2 | 71 | 76 | PF00069 | 0.375 |
MOD_PIKK_1 | 205 | 211 | PF00454 | 0.370 |
MOD_Plk_4 | 126 | 132 | PF00069 | 0.295 |
MOD_Plk_4 | 141 | 147 | PF00069 | 0.308 |
MOD_Plk_4 | 161 | 167 | PF00069 | 0.214 |
MOD_Plk_4 | 175 | 181 | PF00069 | 0.271 |
MOD_Plk_4 | 34 | 40 | PF00069 | 0.309 |
TRG_DiLeu_BaLyEn_6 | 54 | 59 | PF01217 | 0.508 |
TRG_ENDOCYTIC_2 | 154 | 157 | PF00928 | 0.328 |
TRG_ENDOCYTIC_2 | 181 | 184 | PF00928 | 0.326 |
TRG_ENDOCYTIC_2 | 201 | 204 | PF00928 | 0.217 |
TRG_ENDOCYTIC_2 | 215 | 218 | PF00928 | 0.337 |
TRG_ENDOCYTIC_2 | 35 | 38 | PF00928 | 0.298 |
TRG_ENDOCYTIC_2 | 79 | 82 | PF00928 | 0.344 |
TRG_ER_diLys_1 | 281 | 284 | PF00400 | 0.642 |
TRG_NES_CRM1_1 | 242 | 255 | PF08389 | 0.435 |
TRG_NLS_MonoExtC_3 | 136 | 141 | PF00514 | 0.550 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0C5PHQ7 | Tachysurus fulvidraco | 25% | 97% |
A0A0N0P5E5 | Leptomonas seymouri | 32% | 95% |
A0A0N0P7D1 | Leptomonas seymouri | 34% | 85% |
A0A0N0P7D6 | Leptomonas seymouri | 40% | 98% |
A0A0N0P7R2 | Leptomonas seymouri | 37% | 93% |
A0A0N1HZJ8 | Leptomonas seymouri | 28% | 88% |
A0A0N1I9H5 | Leptomonas seymouri | 57% | 100% |
A0A0N1ILQ4 | Leptomonas seymouri | 36% | 97% |
A0A0N1IM10 | Leptomonas seymouri | 47% | 99% |
A0A0N1PDR8 | Leptomonas seymouri | 32% | 100% |
A0A0N1PFE8 | Leptomonas seymouri | 81% | 100% |
A0A0S4IS29 | Bodo saltans | 38% | 100% |
A0A0S4IVJ6 | Bodo saltans | 33% | 89% |
A0A0S4IVS6 | Bodo saltans | 33% | 100% |
A0A0S4IW98 | Bodo saltans | 38% | 90% |
A0A0S4JH58 | Bodo saltans | 25% | 95% |
A0A1X0NNK7 | Trypanosomatidae | 34% | 100% |
A0A1X0NNL0 | Trypanosomatidae | 41% | 94% |
A0A1X0NNM4 | Trypanosomatidae | 38% | 99% |
A0A1X0NNM5 | Trypanosomatidae | 31% | 92% |
A0A1X0NP89 | Trypanosomatidae | 27% | 89% |
A0A3Q8I8T7 | Leishmania donovani | 29% | 72% |
A0A3Q8I9T2 | Leishmania donovani | 31% | 76% |
A0A3Q8I9U9 | Leishmania donovani | 29% | 87% |
A0A3Q8I9X8 | Leishmania donovani | 36% | 85% |
A0A3Q8IC05 | Leishmania donovani | 33% | 93% |
A0A3Q8IIA9 | Leishmania donovani | 95% | 100% |
A0A3R7KG78 | Trypanosoma rangeli | 31% | 100% |
A0A3R7MJR2 | Trypanosoma rangeli | 36% | 100% |
A0A3R7NSQ3 | Trypanosoma rangeli | 43% | 99% |
A0A3S5H6R7 | Leishmania donovani | 49% | 100% |
A0A3S5H6R8 | Leishmania donovani | 36% | 97% |
A0A3S7WSY8 | Leishmania donovani | 57% | 100% |
A0A3S7WSZ1 | Leishmania donovani | 32% | 95% |
A0A3S7WT03 | Leishmania donovani | 34% | 95% |
A0A3S7WT05 | Leishmania donovani | 25% | 93% |
A0A3S7WT16 | Leishmania donovani | 30% | 88% |
A0A422NNP1 | Trypanosoma rangeli | 30% | 95% |
A4H7M1 | Leishmania braziliensis | 24% | 93% |
A4H7M2 | Leishmania braziliensis | 59% | 99% |
A4H7M3 | Leishmania braziliensis | 49% | 100% |
A4H7M4 | Leishmania braziliensis | 90% | 100% |
A4H7M5 | Leishmania braziliensis | 34% | 97% |
A4H7M6 | Leishmania braziliensis | 33% | 95% |
A4H7M7 | Leishmania braziliensis | 31% | 88% |
A4H7M8 | Leishmania braziliensis | 28% | 75% |
A4H7M9 | Leishmania braziliensis | 28% | 70% |
A4H7N0 | Leishmania braziliensis | 34% | 96% |
A4HW06 | Leishmania infantum | 25% | 93% |
A4HW07 | Leishmania infantum | 57% | 100% |
A4HW08 | Leishmania infantum | 49% | 100% |
A4HW09 | Leishmania infantum | 95% | 100% |
A4HW10 | Leishmania infantum | 36% | 97% |
A4HW12 | Leishmania infantum | 36% | 85% |
A4HW13 | Leishmania infantum | 29% | 87% |
A4HW14 | Leishmania infantum | 31% | 88% |
A4HW15 | Leishmania infantum | 31% | 76% |
A4HW17 | Leishmania infantum | 29% | 72% |
A4HW18 | Leishmania infantum | 33% | 94% |
C9ZT13 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 33% | 94% |
C9ZT15 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 34% | 100% |
C9ZT16 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 40% | 93% |
D4A612 | Rattus norvegicus | 28% | 100% |
E9AGL0 | Leishmania infantum | 34% | 95% |
E9AGL2 | Leishmania infantum | 33% | 95% |
E9APQ8 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 26% | 93% |
E9APQ9 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 59% | 76% |
E9APR0 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 48% | 100% |
E9APR1 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 94% | 100% |
E9APR2 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 35% | 97% |
E9APR3 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 35% | 95% |
E9APR4 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 35% | 95% |
E9APR5 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 36% | 85% |
E9APR6 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 29% | 87% |
E9APR7 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 29% | 88% |
E9APR8 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 28% | 74% |
E9APR9 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 32% | 94% |
G5EEE5 | Caenorhabditis elegans | 31% | 99% |
O35949 | Mus musculus | 35% | 100% |
P49191 | Caenorhabditis elegans | 31% | 89% |
Q20300 | Caenorhabditis elegans | 31% | 100% |
Q32NI8 | Xenopus laevis | 27% | 96% |
Q3S8M4 | Macaca mulatta | 26% | 90% |
Q4QFQ9 | Leishmania major | 32% | 100% |
Q4QFR1 | Leishmania major | 29% | 100% |
Q4QFR2 | Leishmania major | 30% | 76% |
Q4QFR3 | Leishmania major | 31% | 100% |
Q4QFR4 | Leishmania major | 29% | 87% |
Q4QFR5 | Leishmania major | 37% | 79% |
Q4QFR6 | Leishmania major | 33% | 100% |
Q4QFR7 | Leishmania major | 36% | 97% |
Q4QFR9 | Leishmania major | 48% | 100% |
Q4QFS0 | Leishmania major | 59% | 100% |
Q4QFS1 | Leishmania major | 25% | 93% |
Q5M8U1 | Xenopus tropicalis | 26% | 96% |
Q5ZJR8 | Gallus gallus | 34% | 100% |
Q6PC64 | Danio rerio | 32% | 100% |
Q920L5 | Mus musculus | 33% | 100% |
Q920L6 | Rattus norvegicus | 36% | 100% |
Q95K73 | Macaca fascicularis | 26% | 90% |
Q9EQC4 | Mus musculus | 24% | 91% |
Q9GZR5 | Homo sapiens | 26% | 90% |
Q9H5J4 | Homo sapiens | 34% | 100% |
Q9HB03 | Homo sapiens | 34% | 100% |
Q9VV87 | Drosophila melanogaster | 33% | 90% |
Q9XVQ9 | Caenorhabditis elegans | 33% | 100% |
V5BE99 | Trypanosoma cruzi | 34% | 99% |
V5BIX9 | Trypanosoma cruzi | 38% | 100% |
V5BND3 | Trypanosoma cruzi | 30% | 95% |
V5DF68 | Trypanosoma cruzi | 41% | 98% |